Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort

BACKGROUND: Fibroblast growth factor 23 (FGF23) has emerged as a risk factor for cardiovascular disease and mortality throughout all stages of chronic kidney disease (CKD), independent from established risk factors and markers of mineral homeostasis. The relation of FGF23 with other renal and non-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Vervloet, Marc G, van Zuilen, Arjan D, Heijboer, Annemieke C, ter Wee, Piet M, Bots, Michiel L, Blankestijn, Peter J, Wetzels, Jack FM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366907/
https://www.ncbi.nlm.nih.gov/pubmed/22530966
http://dx.doi.org/10.1186/1471-2369-13-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366907/
https://www.ncbi.nlm.nih.gov/pubmed/22530966
http://dx.doi.org/10.1186/1471-2369-13-20

Ejemplares similares